Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07581457
NA

Tranexamic Acid in Pediatric Idiopathic Scoliosis Surgery

Sponsor: Poznan University of Medical Sciences

View on ClinicalTrials.gov

Summary

This study will evaluate whether tranexamic acid (TXA), a medication used to reduce bleeding, is effective and safe in children undergoing surgery for idiopathic scoliosis. Significant blood loss is common during this type of surgery and often requires blood transfusions. Participants will be randomly assigned to one of three groups: (1) TXA given as an intravenous bolus followed by continuous infusion, (2) TXA given as two intravenous bolus doses, or (3) placebo (saline). Neither the patients nor the medical team will know which treatment is given. The main goal is to compare how much blood is lost during and after surgery and whether TXA reduces the need for blood transfusions. The study will also assess safety, including the risk of side effects such as seizures or blood clots. Patients will be followed for up to 30 days after surgery.

Official title: Efficacy and Safety of Two Intravenous Tranexamic Acid Regimens Versus Placebo in Pediatric Idiopathic Scoliosis Surgery: A Randomized Double-Blind Trial

Key Details

Gender

All

Age Range

10 Years - 18 Years

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2026-06-01

Completion Date

2027-06-30

Last Updated

2026-07-01

Healthy Volunteers

No

Interventions

DRUG

Tranexamic Acid Bolus Plus Infusion

Tranexamic acid administered intravenously as a 15 mg/kg bolus after induction of anesthesia, followed by continuous infusion at 1 mg/kg/h until the end of surgery.

DRUG

Sodium Chloride 0.9% Inj

Intravenous administration of 0.9% sodium chloride solution used as placebo, matched in volume and timing to the active comparator groups.

DRUG

Tranexamic Acid Bolus Only

Tranexamic acid administered intravenously as two bolus doses: 10 mg/kg after induction of anesthesia and 10 mg/kg 120 minutes after surgical incision or at the beginning of rod placement, whichever occurs first.

Locations (1)

Poznan University of Medical Sciences

Poznan, Poland